Crocodile-derived tripeptide with ACE inhibitory activity as well as preparation method and application thereof
By extracting and preparing tripeptides with amino acid sequence FLW or FAW from alligator meat, the side effects of existing hypertensive drugs are solved, providing a safe and easy-to-absorb natural ACE inhibitor, significantly improving antihypertensive activity , suitable for hypertension treatment.
Patent Information
- Application Number
- CN202411514012.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-29
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-10-29
AI Technical Summary
Existing synthetic drugs used to treat hypertension have side effects and it is difficult to regulate blood pressure safely and effectively, resulting in the treatment of hypertension being an urgent problem.
The tripeptide with ACE inhibitory activity extracted from crocodile meat is prepared by cleaning, crushing, enzymatic decomposition and spray-drying. The amino acid sequence is FLW or FAW, and the molecular weight is small and easy to be absorbed by the human body. Used to prepare ACE inhibitors.
It provides a natural, safe and easy to absorb ACE inhibitor peptide, with a low IC50 value and higher antihypertensive activity. It is suitable for antihypertensive drugs or foods, which significantly improves the effect of treating hypertension.
Smart Images

Figure CN119039382A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to small molecule bioactive peptides and preparation methods and applications thereof, and in particular to a tripeptide derived from crocodile meat and having ACE inhibitory activity and a preparation method and application thereof, belonging to the technical field of bioactive peptides. Background Art
[0002] Hypertension is a common chronic disease, and inhibiting the activity of angiotensin-converting enzyme (ACE) is one of the effective strategies for regulating blood pressure. However, although the synthetic drugs currently used to treat hypertension can effectively regulate blood pressure, they all have certain side effects that affect human health. Safe and effective treatment of hypertension is still an urgent problem to be solved.
[0003] Food-borne ACE inhibitory peptides (ACEIPs) are safe, mild, and easily absorbed, and have become a research hotspot for the prevention and treatment of hypertension.
[0004] Crocodiles are vertebrate reptiles, widely distributed in Vietnam, Thailand, Malaysia and other countries. Studies have shown that crocodile meat has a high protein content, contains a moderate proportion of essential amino acids for the human body, and contains advanced unsaturated fatty acids and a variety of trace elements with high nutritional value for the human body. It has the effects of nourishing the heart and lungs, replenishing blood and strengthening bones, replenishing the kidneys and consolidating essence, and expelling evil spirits and removing dampness. Regular consumption can replenish qi and blood, relieve asthma and cough. The ecological value, scientific value and economic value of crocodiles are extremely high, and the crocodile breeding industry has been actively developed. Summary of the invention
[0005] The purpose of the present invention is to provide a small molecule bioactive peptide derived from crocodile meat, which is safe to eat, mild in effect and easily absorbed by the human body, as well as a preparation method and application thereof.
[0006] In order to achieve the above object, the present invention adopts the following technical solution: A crocodile-derived tripeptide with ACE inhibitory activity is derived from crocodile meat, has an amino acid sequence of FLW or FAW, and has molecular weights of 465.62 Da and 422.76 Da, respectively.
[0007] The method for preparing the aforementioned crocodile-derived tripeptide having ACE inhibitory activity comprises the following steps: (1) washing the crocodile meat, removing the fat tissue and grinding the crocodile meat to obtain crocodile meat paste; (2) adding crocodile meat paste to water at a solid-liquid ratio of 1:10 to obtain a mixture; (3) adjusting the pH value of the mixture to 8, then adding a composite protease prepared by mixing alkaline protease and neutral protease in a mass ratio of 1:1 to obtain a mass concentration of 0.3% of the composite protease, reacting at 53°C for 5 hours to obtain an enzymatic hydrolyzate; (4) heating the enzymatic hydrolysate to inactivate the enzyme, centrifuging and collecting the supernatant to obtain an enzyme-inactivated enzymatic hydrolysate; (5) The enzyme-killed hydrolyzate is spray-dried to obtain crocodile peptide powder, which contains a tripeptide with the amino acid sequences of FLW and FAW.
[0008] Application of the aforementioned crocodile-derived tripeptide having ACE inhibitory activity in the preparation of ACE inhibitors.
[0009] The present invention is beneficial in that: (1) The ACE inhibitory peptide provided by the present invention is derived from edible crocodile meat and is a type of natural ACE inhibitory peptide that is safer for the human body; (2) The ACE inhibitory peptide provided by the present invention is composed of three amino acids (FAW and FLW) and has a small molecular weight (molecular weight is 422.76 and 465.62, respectively), and is more easily absorbed by the human body; (3) IC of the ACE inhibitory peptide provided by the present invention 50 The values are 0.022 mg / mL and 0.117 mg / mL respectively, which are higher in antihypertensive activity than most existing ACE inhibitory peptides and can be used in antihypertensive drugs or compositions, and antihypertensive foods. BRIEF DESCRIPTION OF THE DRAWINGS
[0010] Figure 1 This is the total ion current of the crocodile enzymatic hydrolysate in the blank group; Figure 2 This is the total ion current diagram of the crocodile enzymatic hydrolysate in the experimental group; Figure 3 This is the primary mass spectrum of the tripeptide FLW; Figure 4 This is the secondary mass spectrum of the tripeptide FLW; Figure 5 This is the primary mass spectrum of the tripeptide FAW; Figure 6 This is the secondary mass spectrum of the tripeptide FAW; Figure 7 This is the molecular docking conformation diagram of the tripeptide FAW and ACE; Figure 8 This is the force analysis diagram of the tripeptide FAW and ACE; Fig. 9 This is the calculation result of ACE inhibition rate of tripeptide FLW at different concentrations; Fig.10 This is the calculation result of ACE inhibition rate of tripeptide FAW at different concentrations. DETAILED DESCRIPTION
[0011] The present invention is described in detail below with reference to the accompanying drawings and embodiments.
[0012] 1. Preparation of crocodile peptide powder The crocodile peptide powder was prepared by a composite enzymatic hydrolysis method, and the specific preparation method is as follows: 1. Wash the crocodile meat, remove the fat tissue and grind it to obtain crocodile meat paste; 2. Add crocodile meat paste to water with a material-liquid ratio of 1:10 (1 kg crocodile meat paste: 10 L water) to obtain a mixture; 3. Use a 0.2 mol / L NaOH solution to adjust the pH value of the mixture to 8, then add a certain amount of composite protease (alkaline protease and neutral protease mixed in a mass ratio of 1:1) to the mixture, so that the mass concentration of the composite protease is 0.3%, react at 53°C for 5 hours, and obtain an enzymatic solution; 4. Heat the enzymatic hydrolysate at 90°C for 20 min to inactivate the enzyme, then centrifuge at 4000 r / min for 10 min, take the supernatant, and obtain the inactivated enzymatic hydrolysate; 5. The enzyme-killed enzymolysis solution is spray-dried to obtain crocodile peptide powder.
[0013] 2. Determination of amino acid content of crocodile peptide powder The amino acid content of the obtained crocodile peptide powder was determined according to the method described in the National Standard of the People's Republic of China GB 5009.124-2016 "National Food Safety Standard Determination of Amino Acids in Food".
[0014] The results of amino acid content determination of crocodile peptide powder are shown in Table 1.
[0015] Table 1 Amino acid content of crocodile peptide powder
[0016] *Essential amino acids for the human body.
[0017] It can be seen from Table 1 that hydrophobic amino acids Ser, Leu, Pro, Ile, Phe and positively charged amino acids Lys and Arg have a higher proportion in crocodile peptide powder. Therefore, crocodile peptide powder has the potential to prepare ACE inhibitory peptides.
[0018] 3. Isolation of small molecule bioactive peptides with ACE inhibitory activity from crocodile peptide powder The affinity ultrafiltration method was used to separate the small molecule bioactive peptides with ACE inhibitory activity from the obtained crocodile peptide powder. The separation method is as follows: 1. Add crocodile peptide powder and ACE to water respectively, so that the concentration of crocodile peptide powder is 5 mg / mL and the concentration of ACE is 100 mU / mL, to obtain crocodile peptide powder solution and ACE solution; 2. Experimental group: crocodile peptide powder solution and ACE solution were mixed at a volume ratio of 1:2 and incubated at 37°C for 1 h; 3. Blank group: Heat the ACE solution in a 100°C water bath for 10 min to inactivate it, then mix the crocodile peptide powder solution and the inactivated ACE solution at a volume ratio of 1:2 and incubate at 37°C for 1 h; 4. After the incubation, centrifuge at 4000r / min for 30min in a 10kDa ultrafiltration centrifuge tube, centrifuge three times to remove the peptides that are not bound to ACE and collect the precipitate (the complex formed by the binding of ACE and peptides).
[0019] 5. Mix the collected precipitate with 70% acetonitrile solution in a volume ratio of 1:2, incubate at room temperature for 10 min, and then centrifuge at 4000 r / min for 30 min to release the peptides in the complex. Repeat (mixing the precipitate with the acetonitrile solution - incubation - centrifugation) 3 times, collect the filtrate and spray dry it to obtain crocodile hydrolysate, which contains small molecule bioactive peptides with potential ACE inhibitory activity.
[0020] The total ion current of the blank group crocodile enzymatic hydrolysate is shown in Figure 1 The total ion current of the crocodile hydrolysate in the experimental group is shown in Figure 2 .
[0021] Depend on Figure 1 and Figure 2 It can be seen that the crocodile hydrolysate in the blank group contained 50 small molecule bioactive peptides with potential ACE inhibitory activity, and the crocodile hydrolysate in the experimental group contained 266 small molecule bioactive peptides with potential ACE inhibitory activity.
[0022] 3. Purification of crocodile hydrolysate The obtained crocodile hydrolysate was added with water to prepare a sample solution with a concentration of 50 mg / mL, and the crocodile hydrolysate was purified by high performance liquid chromatography using a gradient elution method. The specific conditions of the high performance liquid chromatography were as follows: 1. Liquid chromatography column: Agilent ZORBAX SB-C18 (5 μm, 250 mm × 4.6 mm); 2. Detection wavelength: 228nm; 3. Sample volume: 10 μL; 4. Flow rate: 1mL / min; 5. Mobile phase: Mobile phase A is a 0.1% formic acid aqueous solution, and mobile phase B is a 0.1% formic acid acetonitrile solution (freshly prepared before use); 6. Gradient elution method: 0min~50min, the volume content of mobile phase B in the mobile phase is 4%~50%, and the volume content of mobile phase A in the mobile phase is 96%~50%; 50min~54min, the volume content of mobile phase B in the mobile phase is 50%~100%, and the volume content of mobile phase A in the mobile phase is 50%~0%; 54min~60min, the volume content of mobile phase B in the mobile phase is 100%.
[0023] 4. Mass spectrometry analysis of the purified product and determination of the amino acid sequence The purified product was analyzed by mass spectrometry using a QExactive mass spectrometer (ThermoFisher). The mass spectrometry analysis conditions were as follows: 1. Analysis time: 60 minutes; 2. Detection method: positive ion; 3. Collection method of peptide and fragment mass-to-charge ratio: collect 10 fragment spectra (MS2scan) after each full scan (fullscan).
[0024] The amino acid sequences of the two purified products with larger peak areas were detected by liquid chromatography-mass spectrometry (LC-MS / MS). The detection results are shown in Table 2.
[0025] Table 2 Peptide sequences with potential ACE inhibitory activity from crocodile meat
[0026] Among them, the primary mass spectrum of the tripeptide FLW is shown in Figure 3 , the secondary mass spectrum is shown in Figure 4 ; The primary mass spectrum of the tripeptide FAW is shown in Figure 5 , the secondary mass spectrum is shown in Figure 6 .
[0027] Depend on Figure 3 and Figure 4 It can be seen that the molecular weight of the tripeptide FLW is 465.62, which is close to its theoretical molecular weight.
[0028] Depend on Figure 5 and Figure 6 It can be seen that the molecular weight of the tripeptide FAW is 422.76, which is close to its theoretical molecular weight.
[0029] 5. Preliminary evaluation of the structure-activity relationship of the purified product by molecular docking The three-dimensional structure of ACE (PDB code: 1O8A) was obtained from the RCSB protein database (www.pdb.org), and the protein and ligand were prepared using the AutoDockTools program. The protein structures in the protein database are saved in the PDB format. After removing water molecules, adding polar hydrogen, calculating the Coleman charge, and merging non-polar hydrogen, they were saved as pdbqt format files. The 3D structures of the two purified products in Table 2 were processed by AutoDockTools and saved as pdbqt format files. The grid center was located at X=40.607, Y=32.451, and Z=43.579, the size of the grid box was 60Å×70Å×52Å, and the grid spacing was 0.375Å. The docking was performed by the AutoDock4.2.6 program, and a total of 100 docking operations were performed to calculate the binding energy (docking score, -CiE) between the two purified products in Table 2 and ACE. The calculation results of the binding energy are shown in Table 3.
[0030] Table 3 ACE binding energy of peptides with potential ACE inhibitory activity
[0031] Among them, the molecular docking conformation diagram of the tripeptide FAW and ACE is shown in Figure 7 , force analysis diagram see Figure 8 .Depend on Figure 8 It can be seen that three hydrogen bonds are formed between the tripeptide FAW and ACE, namely Glu376, Glu384 and Thr282. Hydrogen bonds and electrostatic effects are the main forces that stabilize the ACE-FAW complex.
[0032] This indicates that the tripeptide FAW can bind to ACE through multiple forces to exert antihypertensive activity.
[0033] VI. Verification of the in vitro ACE inhibitory activity of the purified product The two tripeptides FLW and FAW in Table 2 were subjected to solid phase synthesis to obtain two tripeptide powders, which were respectively prepared into sample solutions with a concentration of 1 mg / mL, and then the in vitro ACE inhibitory activity of the two tripeptides was verified by high performance liquid chromatography.
[0034] The specific method for determining ACE inhibition rate is as follows: 1. Sample group: Add 10 μL of 1 mg / mL sample solution and 20 μL of 100 mU / mL ACE solution to a 1.5 mL centrifuge tube and react at 37°C for 5 min. 2. Control group: Add 10 μL ultrapure water and 20 μL 100 mU / mL ACE solution to a 1.5 mL centrifuge tube and react at 37°C for 5 min. 3. Add 30 μL of 2.5 mmol / L hippuric acid histidyl leucine (HHL) solution to the reaction system of the sample group and the control group respectively, and react at 37°C for 1 h. Then, add 60 μL of 1 mol / L HCl solution to terminate the reaction. Finally, add 200 μL of water (dilution) and detect the content of hippuric acid (HA) by high performance liquid chromatography after filtering through a 0.22 μm filter membrane.
[0035] HPLC conditions: 1. Liquid chromatography column: Agilent ZORBAX SB-C18 (5 μm, 250 mm × 4.6 mm); 2. Detection wavelength: 228nm; 3. Sample volume: 5 μL; 4. Flow rate: 0.8 mL / min; 5. Mobile phase: Mobile phase A is 0.1% formic acid aqueous solution, and mobile phase B is acetonitrile; 6. Elution conditions: The volume ratio of mobile phase A to mobile phase B is 41:6.
[0036] The calculation formula of the inhibition rate of ACE activity of each sample (ACE inhibition rate) is as follows:
[0037] Among them, ΔA is the peak area of HA in the control group, and ΔB is the peak area of HA in the sample group.
[0038] It was calculated that the inhibition rates of FLW and FAW tripeptides (at a concentration of 1 mg / mL) on ACE activity were 71% and 92%, respectively, showing good ACE inhibitory activity.
[0039] The tripeptides FLW and FAW were taken to determine their half-inhibitory concentration (IC 50 ).
[0040] The tripeptides FLW and FAW were prepared into different concentrations (1 mg / mL, 0.5 mg / mL, 0.25 mg / mL, 0.125 mg / mL, 0.0625 mg / mL), with the concentration of the tripeptide as the horizontal axis and the ACE inhibition rate of the tripeptide as the vertical axis. The curve was drawn using Origin2021 software, and data conversion and least square method fitting were performed using GraphPad Prism. 50 .
[0041] The calculation results of ACE inhibition rate of tripeptide FLW at different concentrations are shown in Fig. 9 .
[0042] The calculation results of ACE inhibition rate of tripeptide FAW at different concentrations are shown in Fig.10 .
[0043] Depend on Fig. 9 and Fig.10 It can be seen that the ACE inhibition rates of FLW and FAW were positively correlated with the peptide concentration. Among them, the IC 50 The IC value of the tripeptide FAW is 0.117 mg / mL. 50 It is 0.022 mg / mL. It can be seen that the two tripeptides are more active than most existing ACE inhibitory peptides and have more prominent antihypertensive activity.
[0044] Phenylalanine-alanine-tryptophan (Phe-Ala-Trp, FAW), theoretical molecular weight is 422.49, molecular formula is C 23 H 26 N 4 O 4 , the structural formula is as follows: .
[0045] Alanine-leucine-tryptophan (Phe-Leu-Trp, FLW), theoretical molecular weight is 464.57, molecular formula is C 26 H 32 N 4 O 4 , the structural formula is as follows: .
[0046] In summary, the tripeptides FLW and FAW provided by the present invention are derived from edible crocodile meat, are a type of natural ACE inhibitory peptides, and are safer; both are composed of 3 amino acids, have a small molecular weight, and are more easily absorbed by the human body; and, after testing, the IC 50 The concentrations of the tripeptides FLW and FAW are 0.117 mg / mL and 0.022 mg / mL respectively, and the ACE inhibition effect is outstanding. Therefore, the tripeptides FLW and FAW provided by the present invention can be applied to the field of antihypertensive drugs or compositions, and antihypertensive foods.
[0047] It should be noted that the above embodiments of the present invention are merely examples for clearly illustrating the present invention, and are not intended to limit the embodiments of the present invention. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is impossible to list all the embodiments here. Any obvious changes or modifications derived from the technical solution of the present invention are still within the scope of protection of the present invention.
Claims
1. A crocodile-derived tripeptide having ACE inhibitory activity, characterized in that: The tripeptide is derived from crocodile meat, has an amino acid sequence of FLW or FAW, and has molecular weights of 465.62 Da and 422.76 Da, respectively.
2. The method for preparing the crocodile-derived tripeptide having ACE inhibitory activity according to claim 1, characterized in that: The following steps are involved: (1) washing the crocodile meat, removing the fat tissue and grinding the crocodile meat to obtain crocodile meat paste; (2) adding crocodile meat paste to water at a solid-liquid ratio of 1:10 to obtain a mixture; (3) adjusting the pH value of the mixture to 8, then adding a composite protease prepared by mixing alkaline protease and neutral protease in a mass ratio of 1:1 to obtain a mass concentration of 0.3% of the composite protease, reacting at 53°C for 5 hours to obtain an enzymatic hydrolyzate; (4) heating the enzymatic hydrolysate to inactivate the enzyme, centrifuging and collecting the supernatant to obtain an enzyme-inactivated enzymatic hydrolysate; (5) The enzyme-killed hydrolyzate is spray-dried to obtain crocodile peptide powder, which contains a tripeptide with the amino acid sequences of FLW and FAW.
3. Use of the crocodile-derived tripeptide having ACE inhibitory activity according to claim 1 in the preparation of ACE inhibitors.
Citation Information
Patent Citations
Tuna white meat ACE inhibitory peptide and preparation method thereof
CN110724178A
ACE inhibitory peptide as well as preparation method and application thereof
CN117551170A
Peptide-conjugated prodrugs
US20220387610A1
Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance
WO2014134225A2
Cited By
Tripeptide, tripeptide salt or derivative and application thereof
CN118530299A
A tripeptide, a tripeptide salt or a derivative and its application
CN118530299B
